Premium
CHECKPOINT INHIBITION BEFORE HAPLOIDENTICAL TRANSPLANTATION IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA PATIENTS IS ASSOCIATED WITH HIGHER PFS WITHOUT INCREASED TOXICITIES
Author(s) -
Philippis C.,
Legrande F.,
Bramanti S.,
Montes de Oca C.,
Dulery R.,
Bouabdallah R.,
Granada A.,
Devillier R.,
Mariotti J.,
Sarina B.,
Harbi S.,
Maisano V.,
Furst S.,
Pagliardini T.,
Weiller P.J.,
Lemarie C.,
Calmels B.,
Chaban C.,
CarloStella C.,
Santoro A.,
Mohty M.,
Blaise D.,
Castagna L.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.107_2630
Subject(s) - medicine , nivolumab , oncology , refractory (planetary science) , lymphoma , cyclophosphamide , transplantation , incidence (geometry) , surgery , chemotherapy , immunotherapy , cancer , astrobiology , physics , optics